Cited by

• High sensitivity to peripheral blood lymphocytes and low HLA-class I antigen expression of small cell lung cancer cell lines with diverse chemo-radiosensitivity.

  Tanio Y, Watanabe M, Osaki T, Tachibana I, Kawase I, Kuritani T, Saito S, Masuno T, Kodama N, Furuse K, et al. Tanio Y, et al. Jpn J Cancer Res. 1992 Jul;83(7):736-45. doi: 10.1111/j.1349-7006.1992.tb01974.x. Jpn J Cancer Res. 1992. PMID: 1325431 Free PMC article.
• Endogenous interferon alpha/beta produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor alpha production and interleukin-2-induced activation of nonparenchymal liver cells.

  Tzung SP, Cohen SA. Tzung SP, et al. Cancer Immunol Immunother. 1991;34(3):150-6. doi: 10.1007/BF01742305. Cancer Immunol Immunother. 1991. PMID: 1756531 Free PMC article.
• Immunoreactive alpha interferon in cervical flat koilocytic lesions and intraepithelial neoplasia.

  Stewart CJ, Farquharson MA, McNicol AM, Foulis AK. Stewart CJ, et al. J Clin Pathol. 1990 Mar;43(3):230-4. doi: 10.1136/jcp.43.3.230. J Clin Pathol. 1990. PMID: 2159031 Free PMC article.
• Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3.

  von Gamm M, Schaub A, Jones AN, Wolf C, Behrens G, Lichti J, Essig K, Macht A, Pircher J, Ehrlich A, Davari K, Chauhan D, Busch B, Wurst W, Feederle R, Feuchtinger A, Tschöp MH, Friedel CC, Hauck SM, Sattler M, Geerlof A, Hornung V, Heissmeyer V, Schulz C, Heikenwalder M, Glasmacher E. von Gamm M, et al. J Exp Med. 2019 Jul 1;216(7):1700-1723. doi: 10.1084/jem.20181762. Epub 2019 May 24. J Exp Med. 2019. PMID: 31126966 Free PMC article.
• Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.

  Fiorentino B, Di Stefano P, Giuliani C, Amatetti C, Tinari N, Natoli C, Garufi C, Iacobelli S. Fiorentino B, et al. Br J Cancer. 1992 Nov;66(5):981-3. doi: 10.1038/bjc.1992.396. Br J Cancer. 1992. PMID: 1419647 Free PMC article. Clinical Trial. No abstract available.